 | • レポートコード：MRC2-11QY04388 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は前立腺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬）市場規模、用途別（病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別前立腺がん治療薬の競争状況、市場シェア ・世界の前立腺がん治療薬市場：種類別市場規模 2015年-2020年（LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬） ・世界の前立腺がん治療薬市場：種類別市場規模予測 2021年-2026年（LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬） ・世界の前立腺がん治療薬市場：用途別市場規模 2015年-2020年（病院、その他） ・世界の前立腺がん治療薬市場：用途別市場規模予測 2021年-2026年（病院、その他） ・北米の前立腺がん治療薬市場分析：米国、カナダ ・ヨーロッパの前立腺がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの前立腺がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の前立腺がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの前立腺がん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca plc、Active Biotech、Bristol Myers-Squibb、Teva Pharmaceuticals Industries Ltd.、Johnson & Johnson、Pfizer Inc.、Bayer AG、Abbott Laboratories、Astellas Pharma Inc.、Roche Holding AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.
Market Analysis and Insights: Global Prostate Cancer Medicine Market
The global Prostate Cancer Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prostate Cancer Medicine Scope and Market Size
Prostate Cancer Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
Market segment by Type, the product can be split into
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy
Market segment by Application, split into
Hospitals
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
1.4 Market by Type
1.4.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 LHRH Antagonists
1.4.3 LHRH Analogs
1.4.4 Antiandrogens
1.4.5 Pipeline Drugs for Hormonal Therapy
1.5 Market by Application
1.5.1 Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Medicine Market Perspective (2015-2026)
2.2 Global Prostate Cancer Medicine Growth Trends by Regions
2.2.1 Prostate Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prostate Cancer Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Cancer Medicine Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Medicine Players by Market Size
3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Medicine Market Concentration Ratio
3.2.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2019
3.3 Prostate Cancer Medicine Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Medicine Product Solution and Service
3.5 Date of Enter into Prostate Cancer Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Prostate Cancer Medicine Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate Cancer Medicine Market Size (2015-2020)
6.2 Prostate Cancer Medicine Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Medicine Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Medicine Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate Cancer Medicine Market Size (2015-2020)
7.2 Prostate Cancer Medicine Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Medicine Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Medicine Market Size by Application (2015-2020)
8 China
8.1 China Prostate Cancer Medicine Market Size (2015-2020)
8.2 Prostate Cancer Medicine Key Players in China (2019-2020)
8.3 China Prostate Cancer Medicine Market Size by Type (2015-2020)
8.4 China Prostate Cancer Medicine Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate Cancer Medicine Market Size (2015-2020)
9.2 Prostate Cancer Medicine Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Medicine Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Medicine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate Cancer Medicine Market Size (2015-2020)
10.2 Prostate Cancer Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Medicine Market Size by Application (2015-2020)
11 India
11.1 India Prostate Cancer Medicine Market Size (2015-2020)
11.2 Prostate Cancer Medicine Key Players in India (2019-2020)
11.3 India Prostate Cancer Medicine Market Size by Type (2015-2020)
11.4 India Prostate Cancer Medicine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate Cancer Medicine Market Size (2015-2020)
12.2 Prostate Cancer Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Medicine Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Medicine Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca plc
13.1.1 AstraZeneca plc Company Details
13.1.2 AstraZeneca plc Business Overview
13.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
13.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2015-2020))
13.1.5 AstraZeneca plc Recent Development
13.2 Active Biotech
13.2.1 Active Biotech Company Details
13.2.2 Active Biotech Business Overview
13.2.3 Active Biotech Prostate Cancer Medicine Introduction
13.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2015-2020)
13.2.5 Active Biotech Recent Development
13.3 Bristol Myers-Squibb
13.3.1 Bristol Myers-Squibb Company Details
13.3.2 Bristol Myers-Squibb Business Overview
13.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
13.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2015-2020)
13.3.5 Bristol Myers-Squibb Recent Development
13.4 Teva Pharmaceuticals Industries Ltd.
13.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
13.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
13.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
13.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2015-2020)
13.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
13.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Details
13.6.2 Pfizer Inc. Business Overview
13.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
13.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2015-2020)
13.6.5 Pfizer Inc. Recent Development
13.7 Bayer AG
13.7.1 Bayer AG Company Details
13.7.2 Bayer AG Business Overview
13.7.3 Bayer AG Prostate Cancer Medicine Introduction
13.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2015-2020)
13.7.5 Bayer AG Recent Development
13.8 Abbott Laboratories
13.8.1 Abbott Laboratories Company Details
13.8.2 Abbott Laboratories Business Overview
13.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
13.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2015-2020)
13.8.5 Abbott Laboratories Recent Development
13.9 Astellas Pharma Inc.
13.9.1 Astellas Pharma Inc. Company Details
13.9.2 Astellas Pharma Inc. Business Overview
13.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
13.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2015-2020)
13.9.5 Astellas Pharma Inc. Recent Development
13.10 Roche Holding AG
13.10.1 Roche Holding AG Company Details
13.10.2 Roche Holding AG Business Overview
13.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
13.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2015-2020)
13.10.5 Roche Holding AG Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Prostate Cancer Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Medicine Revenue
Table 3. Ranking of Global Top Prostate Cancer Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of LHRH Antagonists
Table 6. Key Players of LHRH Analogs
Table 7. Key Players of Antiandrogens
Table 8. Key Players of Pipeline Drugs for Hormonal Therapy
Table 9. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Prostate Cancer Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Prostate Cancer Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Prostate Cancer Medicine Market Share by Regions (2015-2020)
Table 13. Global Prostate Cancer Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Prostate Cancer Medicine Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Prostate Cancer Medicine Market Growth Strategy
Table 19. Main Points Interviewed from Key Prostate Cancer Medicine Players
Table 20. Global Prostate Cancer Medicine Revenue by Players (2015-2020) (Million US$)
Table 21. Global Prostate Cancer Medicine Market Share by Players (2015-2020)
Table 22. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2019)
Table 23. Global Prostate Cancer Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Prostate Cancer Medicine Product Solution and Service
Table 26. Date of Enter into Prostate Cancer Medicine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 29. Global Prostate Cancer Medicine Market Size Share by Type (2015-2020)
Table 30. Global Prostate Cancer Medicine Revenue Market Share by Type (2021-2026)
Table 31. Global Prostate Cancer Medicine Market Size Share by Application (2015-2020)
Table 32. Global Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 33. Global Prostate Cancer Medicine Market Size Share by Application (2021-2026)
Table 34. North America Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 36. North America Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 37. North America Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 38. North America Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 39. North America Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 40. Europe Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 42. Europe Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 44. Europe Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 46. China Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 47. China Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 48. China Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 49. China Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 50. China Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 51. China Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 52. Japan Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 54. Japan Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 56. Japan Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 60. Southeast Asia Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 62. Southeast Asia Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 64. India Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 65. India Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 66. India Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 67. India Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 68. India Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 69. India Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Prostate Cancer Medicine Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Prostate Cancer Medicine Market Share (2019-2020)
Table 72. Central & South America Prostate Cancer Medicine Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Prostate Cancer Medicine Market Share by Type (2015-2020)
Table 74. Central & South America Prostate Cancer Medicine Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Prostate Cancer Medicine Market Share by Application (2015-2020)
Table 76. AstraZeneca plc Company Details
Table 77. AstraZeneca plc Business Overview
Table 78. AstraZeneca plc Product
Table 79. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 80. AstraZeneca plc Recent Development
Table 81. Active Biotech Company Details
Table 82. Active Biotech Business Overview
Table 83. Active Biotech Product
Table 84. Active Biotech Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 85. Active Biotech Recent Development
Table 86. Bristol Myers-Squibb Company Details
Table 87. Bristol Myers-Squibb Business Overview
Table 88. Bristol Myers-Squibb Product
Table 89. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 90. Bristol Myers-Squibb Recent Development
Table 91. Teva Pharmaceuticals Industries Ltd. Company Details
Table 92. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 93. Teva Pharmaceuticals Industries Ltd. Product
Table 94. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 95. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 100. Johnson & Johnson Recent Development
Table 101. Pfizer Inc. Company Details
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. Product
Table 104. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 105. Pfizer Inc. Recent Development
Table 106. Bayer AG Company Details
Table 107. Bayer AG Business Overview
Table 108. Bayer AG Product
Table 109. Bayer AG Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 110. Bayer AG Recent Development
Table 111. Abbott Laboratories Business Overview
Table 112. Abbott Laboratories Product
Table 113. Abbott Laboratories Company Details
Table 114. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 115. Abbott Laboratories Recent Development
Table 116. Astellas Pharma Inc. Company Details
Table 117. Astellas Pharma Inc. Business Overview
Table 118. Astellas Pharma Inc. Product
Table 119. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 120. Astellas Pharma Inc. Recent Development
Table 121. Roche Holding AG Company Details
Table 122. Roche Holding AG Business Overview
Table 123. Roche Holding AG Product
Table 124. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2015-2020) (Million US$)
Table 125. Roche Holding AG Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Medicine Market Share by Type: 2020 VS 2026
Figure 2. LHRH Antagonists Features
Figure 3. LHRH Analogs Features
Figure 4. Antiandrogens Features
Figure 5. Pipeline Drugs for Hormonal Therapy Features
Figure 6. Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Other Case Studies
Figure 9. Prostate Cancer Medicine Report Years Considered
Figure 10. Global Prostate Cancer Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prostate Cancer Medicine Market Share by Regions: 2020 VS 2026
Figure 12. Global Prostate Cancer Medicine Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prostate Cancer Medicine Market Share by Players in 2019
Figure 15. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2019
Figure 17. North America Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prostate Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 前立腺がん治療の世界市場（～2026年） Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race. Market Analysis and Insights: Global Prostate Cancer Treatment Market The global Prostate Cancer Treatment market size is projected to reach US$ XX m…
- 去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…
- 前立腺がんバイオマーカーの世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. Market Analysis and Insights: Global Prostate Cancer Biomarker Market The gl…